Hagit Peretz Soroka, PhD
Program Manager/Scientific Associate
Princess Margaret Cancer Centre/Sarcoma Program
Since beginning her B.Sc., Dr. Hagit Peretz Soroka has been inspired by the words of the 1937 Nobel Prize-winning scientist, Albert Szent-Gyorgyi:
“Discovery consists of seeing what everybody has seen, and thinking what nobody has thought.”
Throughout, Hagit has striven to bridge the boundaries of chemistry, biology, physics and materials science. Over the years, she built rapport with leading scientists, physicians, investors, donors, patent attorneys, due diligence and
technology transfer departments.
After completion of a masters degree in Neuronal Tissue-Engineering.she worked on the development of autologous stem cell therapies for neurodegenerative diseases and cancer. She received her Ph.D. at Tel Aviv University focusing on the development of novel multidisciplinary nano-biochemical tools for cancer diagnosis and therapy, specifically concentrating on the metabolic activity of the immune system. During this period, Hagit led advanced analysis using data mining tools and machine learning for kit development and commercial enhancement. As well, she wrote several patents and a spin-off company was established on the basis of her Ph.D research.
Before Hagit joined CanSaRCC she completed an NSERC associate Postdoc in the Faculty of Science at the University of Manitoba to explore a new biophysical hypothesis for cell motility that is further related to immune-cancer cell interactions using microfluidic devices. Hagit brings multi-disciplinary experience and expertise in assisting Dr. Abha Gupta to create and lead CanSaRCC in all aspects of its mission.